In silico prediction of telomerase reverse transcriptase inhibitors using modified retinol for the treatment of arsenical cancer

Retinol molecule was modified to predict the inhibitors of telomerase reverse transcriptase for the treatment of arsenical cancer through in silico study. Telomerase activity is expressed in the cancerous conditions which can be the target for anticancer activity by inhibiting telomerase reverse tra...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Kipchu Tshering, Mir Misbahuddin
Natura: Artigo
Lingua:Inglês
Pubblicazione: Bangabandhu Sheikh Mujib Medical University 2016-09-01
Serie:Bangabandhu Sheikh Mujib Medical University Journal
Soggetti:
Arsenic
Cancer
In silico
Molecular docking
Retinol
Telomerase reverse transcriptase
Accesso online:https://www.banglajol.info/index.php/BSMMUJ/article/view/29650
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi